Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges.
The development of safe and effective vaccines in a record time after the emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a remarkable achievement, partly based on the experience gained from multiple viral outbreaks in the past decades. However, the Coronavirus Disea...
Main Authors: | Olivier Terrier, Mustapha Si-Tahar, Mariette Ducatez, Christophe Chevalier, Andrés Pizzorno, Ronan Le Goffic, Thibaut Crépin, Gaëlle Simon, Nadia Naffakh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-12-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1010106 |
Similar Items
-
Impact of the influenza protein PB1-F2 on the biochemical composition of human epithelial cells revealed by synchrotron Fourier transform infrared spectromicroscopy
by: Olivier Leymarie, et al.
Published: (2019-10-01) -
The Known Into the Unknown
by: Antonio Sorgente, MD, PhD, et al.
Published: (2020-07-01) -
The known and the unknown
by: Editorial
Published: (2010-01-01) -
The known knowns and known unknowns of peacekeeping data
by: Dorussen, H, et al.
Published: (2016) -
The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns”
by: Jasper Fuk-Woo Chan, et al.
Published: (2013-07-01)